NEXGEL, Inc. (NXGL)
NASDAQ$2.789
Market Cap
$18.94M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
228 of 924
Rank in Industry
14 of 47
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
NXGL Insider Trading Activity
NXGL Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $233,119 | 11 | 61 |
Sells | $85,475 | 7 | 39 |
Related Transactions
| Drapczuk Adam E III | Chief Financial Officer | 2 | $73,125 | 0 | $0 | $73,125 |
| glassman steven mark | director | 2 | $49,998 | 0 | $0 | $49,998 |
| Stein John Nachum | director | 2 | $34,999 | 0 | $0 | $34,999 |
| ZELDIS JEROME B | director | 2 | $34,999 | 0 | $0 | $34,999 |
| Henry Scott Robert | director | 2 | $30,000 | 4 | $42,451 | $-12,451 |
| Levy Adam R. | Chief Executive Officer | 1 | $9,999 | 3 | $43,024 | $-33,025 |
About NEXGEL, Inc.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Insider Activity of NEXGEL, Inc.
Over the last 12 months, insiders at NEXGEL, Inc. have bought $233,119 and sold $85,475 worth of NEXGEL, Inc. stock.
On average, over the past 5 years, insiders at NEXGEL, Inc. have bought $220,884 and sold $85,475 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Drapczuk Adam E III (Chief Financial Officer) — $73,125. glassman steven mark (director) — $49,998. Stein John Nachum (director) — $34,999.
The last purchase of 3,636 shares for transaction amount of $9,999 was made by Stein John Nachum (director) on 2024‑11‑20.
List of Insider Buy and Sell Transactions, NEXGEL, Inc.
| 2025-03-10 | Sale | Henry Scott Robert | director | 3,000 0.045% | $2.87 | $8,621 | +0.71% | |
| 2025-03-03 | Sale | Levy Adam R. | Chief Executive Officer | 4,000 0.0646% | $3.16 | $12,639 | 0.00% | |
| 2025-02-10 | Sale | Henry Scott Robert | director | 3,000 0.0434% | $3.27 | $9,798 | -4.62% | |
| 2025-02-03 | Sale | Levy Adam R. | Chief Executive Officer | 4,000 0.0561% | $3.64 | $14,558 | -12.81% | |
| 2025-01-07 | Sale | Henry Scott Robert | director | 3,000 0.0419% | $3.37 | $10,097 | -4.56% | |
| 2025-01-02 | Sale | Levy Adam R. | Chief Executive Officer | 4,000 0.0627% | $3.96 | $15,828 | -12.01% | |
| 2024-12-20 | Sale | Henry Scott Robert | director | 3,000 0.0441% | $4.64 | $13,935 | -28.12% | |
| 2024-11-20 | Stein John Nachum | director | 3,636 0.0323% | $2.75 | $9,999 | +4.24% | ||
| 2024-11-20 | Levy Adam R. | Chief Executive Officer | 3,636 0.0323% | $2.75 | $9,999 | +4.24% | ||
| 2024-11-20 | glassman steven mark | director | 9,090 0.0807% | $2.75 | $24,998 | +4.24% | ||
| 2024-11-20 | Henry Scott Robert | director | 1,818 0.0161% | $2.75 | $5,000 | +4.24% | ||
| 2024-11-20 | ZELDIS JEROME B | director | 3,636 0.0323% | $2.75 | $9,999 | +4.24% | ||
| 2024-11-20 | Drapczuk Adam E III | Chief Financial Officer | 17,500 0.1553% | $2.75 | $48,125 | +4.24% | ||
| 2024-08-23 | Stein John Nachum | director | 10,000 0.1028% | $2.50 | $25,000 | +21.44% | ||
| 2024-08-23 | Henry Scott Robert | director | 10,000 0.1028% | $2.50 | $25,000 | +21.44% | ||
| 2024-08-23 | glassman steven mark | director | 10,000 0.1028% | $2.50 | $25,000 | +21.44% | ||
| 2024-08-23 | ZELDIS JEROME B | director | 10,000 0.1028% | $2.50 | $25,000 | +21.44% | ||
| 2024-08-23 | Drapczuk Adam E III | Chief Financial Officer | 10,000 0.1028% | $2.50 | $25,000 | +21.44% | ||
| 2024-03-01 | Henry Scott Robert | director | 23,697 0.3606% | $2.11 | $50,001 | +14.05% | ||
| 2024-03-01 | glassman steven mark | director | 11,848 0.1803% | $2.11 | $24,999 | +14.05% |
Total: 57
*Gray background shows transactions not older than one year
Insider Historical Profitability
3.53%
| Stein John Nachum | director | 471456 6.9426% | $1.31M | 10 | 0 | +18.4% |
| Levy Adam R. | Chief Executive Officer | 374284 5.5117% | $1.04M | 1 | 3 | |
| glassman steven mark | director | 154155 2.2701% | $429,938.30 | 6 | 0 | <0.0001% |
| Henry Scott Robert | director | 138053 2.0329% | $385,029.82 | 14 | 4 | +2.86% |
| ZELDIS JEROME B | director | 106664 1.5707% | $297,485.90 | 4 | 0 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
NXGL Institutional Investors: Active Positions
| Increased Positions | 9 | +81.82% | 272,073 | +119.02% |
| Decreased Positions | 3 | -27.27% | 35,399 | -15.49% |
| New Positions | 5 | New | 51,687 | New |
| Sold Out Positions | 2 | Sold Out | 34,592 | Sold Out |
| Total Postitions | 17 | +54.55% | 465,261 | +103.54% |
NXGL Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Renaissance Technologies Llc | $491.00 | 2.26% | 158,331 | +129,876 | +456.43% | 2024-12-31 |
| Morgan Stanley | $272.00 | 1.25% | 87,804 | +86,204 | +5,387.75% | 2024-12-31 |
| Geode Capital Management, Llc | $186.00 | 0.86% | 60,142 | +3,302 | +5.81% | 2024-12-31 |
| Vanguard Group Inc | $155.00 | 0.71% | 49,975 | 0 | 0% | 2024-12-31 |
| Simon Quick Advisors, Llc | $111.00 | 0.51% | 35,715 | 0 | 0% | 2024-12-31 |
| Newedge Advisors, Llc | $63.00 | 0.29% | 20,295 | +1,004 | +5.21% | 2024-12-31 |
| State Street Corp | $54.00 | 0.25% | 17,259 | +17,259 | New | 2024-12-31 |
| Two Sigma Securities, Llc | $37.00 | 0.17% | 12,035 | +12,035 | New | 2024-12-31 |
| Ifp Advisors, Inc | $34.00 | 0.16% | 11,000 | +11,000 | New | 2024-12-31 |
| Virtu Financial Llc | $33.00 | 0.15% | 10,786 | +10,786 | New | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.